Cargando…
Infusion of umbilical cord mesenchymal stem cells alleviates symptoms of ankylosing spondylitis
The current study evaluated 5 patients with ankylosing spondylitis (AS). Patients received intravenous transfusions of umbilical cord mesenchymal stem cells (uMSCs). All therapeutic and adverse responses were assessed and recorded during uMSC therapy. No severe adverse reactions were observed in any...
Autores principales: | Li, Ai, Tao, Yuan, Kong, Dexiao, Zhang, Ni, Wang, Yongjing, Wang, Zhilun, Wang, Yingxue, Wang, Juandong, Xiao, Juan, Jiang, Yang, Liu, Xiaoli, Zheng, Chengyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526206/ https://www.ncbi.nlm.nih.gov/pubmed/28781629 http://dx.doi.org/10.3892/etm.2017.4687 |
Ejemplares similares
-
Laminin 411 acts as a potent inducer of umbilical cord mesenchymal stem cell differentiation into insulin-producing cells
por: Qu, Huiting, et al.
Publicado: (2014) -
Evaluation of preclinical efficacy of human umbilical cord mesenchymal stem cells in ankylosing spondylitis
por: Shen, Danpeng, et al.
Publicado: (2023) -
Clinical presentation of hemophagocytic lymphohistiocytosis in adults is less typical than in children
por: Zhang, Zuojuan, et al.
Publicado: (2016) -
Efficacy and safety of umbilical cord mesenchymal stem cells for the treatment of patients with COVID-19
por: Wei, Fengtao, et al.
Publicado: (2021) -
Mesenchymal stem cells significantly improved treatment effects of Linezolid on severe pneumonia in a rabbit model
por: Kong, Dexiao, et al.
Publicado: (2019)